Navigation Links
Novartis Oncology Launches GIST Alliance™ for Patients and Caregivers
Date:1/29/2009

Novartis Oncology is introducing GIST Alliance™, a unique support program with the goal to help healthcare professionals optimize outcomes in KIT-positive GIST patients.

East Hanover, NJ (PRWEB) January 29, 2009 -- Gastrointestinal stromal tumors (GISTs) are soft tissue sarcomas. GISTs are rare cancer tumors which usually appear in the stomach or small intestine and are most often (95% of the time) characterized by the presence of a defective KIT protein. Abnormal KIT-positive (KIT+) cells multiply out of control, forming a tumor.

Novartis Oncology is introducing GIST Alliance™, a unique support program with a significant goal: to help optimize patient outcomes in KIT-positive GIST patients.

There are an estimated 3,300 to 6,000 new GIST cases reported each year in the United States (1,2). At diagnosis, approximately 2,500 of these cases are metastatic--cancer that has spread from its original site in the body to another location (3).

Novartis Oncology, the global leader in KIT-positive gastrointestinal stromal tumor (KIT+ GIST) therapy, has been working with healthcare professionals and patients worldwide to help improve the treatment of KIT+ GIST. GIST Alliance is a distinctive, integrated program that builds on the support and educational materials that Novartis Oncology has been providing to patients and healthcare professionals by offering access to the most current resources.

For GIST patients and caregivers, GIST Alliance provides and facilitates access to:


    Source: PRWeb
    Copyright©2009 Vocus, Inc.
    All rights reserved

    2

    GOOD

    Page: 1 2

    Related medicine news :

    1. Novartis Vaccines Launches National Gift-Giving Program to Help Protect Loved Ones by Reserving an Influenza Vaccination
    2. Colorado Influenza and Pneumococcal Alert Coalition (CIPAC) Partners with Novartis Vaccines for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    3. Novartis Vaccines Partners With RediClinic for Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    4. Novartis Vaccines to Host Holiday Vaccination Clinic, Making Influenza Vaccination Convenient for Shoppers
    5. Watson and Novartis Settle Lawsuit Over Exelon(R) Patent Litigation
    6. Novartis and Sony Pictures Television Internationals Latin American Advertising Sales Group Launch Partnership to Create Multi-Media Platform for Breast Cancer Awareness, Detection, and Treatment in Latin America
    7. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
    8. Novartis, Pfizer and Merck Take the Lead on Strong Relationships with Physicians, as Doctors Demand an Expanding Set of Services
    9. Novartis Pharmaceuticals Corporation to Appeal Judgment in Alabama Pricing Case
    10. Novartis Makes Accessing Prescription Assistance and Disease Management Programs Simpler and Easier for Patients
    11. Mylan Announces Settlement Agreement with Novartis Related to Femara(R) First- to-File Opportunity

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/28/2009)... -- Get ready for advanced visualization to bec...en Siemens introduces syngo. via(1) at the ... Radiological Society of North America (RSNA) from...th #825, East Building/Lakeside Center, Hall D) in...maging software for multimodality reading of clini...
    (Date:11/28/2009)...cognize signs of depression , , SATURDAY...e holiday season can trigger melancholy as they th...sues or worry about money problems, according to t...ome the seasonal blues, the AGS Foundation for Hea...out and socialize or invite family and friends ove...
    (Date:11/27/2009)...ikins Ltd. today issued its latest biochemical ana...at the lethality of the virus has dropped from its... outbreak in the spring of 2009 to resting non-epi... infectivity count, however, remains increased. ,...7, 2009 -- Biotech firm Replikins Ltd., which has ...
    (Date:11/27/2009)...swire-USNewswire/ -- Preventing disease is the goa...ery year, new vaccines are being added to assist i...munity for the same period of time? And, if not, w...immunity strong? ,, In this month,s issue of ... Pediatrics, Michael Pichichero MD, Director of th...
    (Date:11/27/2009)... has announced that it has become a national spons... nonprofit organizations dedicated to arthritis re... Delray Beach, FL (Vocus) November 27,...company specializing in the marketing and retail d...nnounced today that is has become a national spons...
    Breaking Medicine News(10 mins):Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 2Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 3Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 4Health News:Siemens Boosts Advanced Image Reading Efficiency and Opens New Path Into The Clinical Routine with syngo(R).via 5Health News:Seniors May Need Help Overcoming Holiday Blues 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4
    ...ith eye docs, says researcher , , THURSDAY... expect the eye doctor,s office to be the last pla... recent research suggests that most people would a...ery important to their sense of well-being, accord...
    ... (Nasdaq:,CYBX) today announced that Dan Moore, Pr...ne, Vice President, Finance and Chief Financial,Of...s Conference in New,York on Wednesday, September 2...S will host a webcast of the presentation,live and...
    ...ly also has serious consequences for the children,...i from Uppsala University has studied women and th..., among other things, that children whose mothers ...ildren,s Health, monitored more than 3,000 childre...
    ...., headquartered in,Orlando, FL, a leading provide...e award-winning predictive analytics, announced to...ashville, TN, one of its clients, a state,Medicaid... The presentation will demonstrate how MEDai,s pr...
    ...er,Services, Inc. (NYSE: ACS ) today announced th...ssistance Program (EPAP), now activated for,reside... Gustav., The EPAP program, established by the Ce...lth insurance living in, or,evacuated from, declar...
    ...centToSleep.com,which specializes in the productio...il sleep mist, appears on the magazine cover "Arom... "Wish you could sleep like a baby?" was researche...ht., ScentToSleep.com is filling a niche in the s...
    Other Medicine News:Health News:Spiritual Beliefs Part of Health Care for Some 2Health News:Spiritual Beliefs Part of Health Care for Some 3Health News:Cyberonics to Present at UBS Global Life Sciences Conference 2Health News:MEDai's Predictive Analytics Impact How State Medicaid Agencies Triage High- Risk Members 2Health News:ACS Facilitates Emergency Prescription Assistance Program Now Activated in Southern Louisiana 2Health News:ScentToSleep.com Is Pleased to Announce That the Company Was Featured in the September 15th Issue of Woman's World Magazine 2
    (Date:11/25/2009)...25 Pharmasset, Inc. (Nas...any committed to discovering, developing and comme...reported financial results for the fiscal year end...asset held $58.4 million in cash, cash equivalents...te and 2009 Highlights ,, RG7128 ,, Pha...
    (Date:11/25/2009)...zerland, Nov. 25 From November 16...e hearing solutions, presented the second edition ...g on the special needs of the older population. Th...ging and audiology from around the world and more ...eople with hearing loss for an opportunity to shar...
    (Date:11/25/2009)...25 The FDA granted traditional app...non-nucleoside reverse transcriptase inhibitor (NN...icated for use in treatment-experienced adults who...ains resistant to an NNRTI and other antiretrovira... on 48-week data from two Phase 3 studies known as...
    Breaking Medicine Technology:Pharmasset Reports Fiscal Year End 2009 Financial Results 2Pharmasset Reports Fiscal Year End 2009 Financial Results 3Pharmasset Reports Fiscal Year End 2009 Financial Results 4Pharmasset Reports Fiscal Year End 2009 Financial Results 5Pharmasset Reports Fiscal Year End 2009 Financial Results 6Pharmasset Reports Fiscal Year End 2009 Financial Results 7Pharmasset Reports Fiscal Year End 2009 Financial Results 8Pharmasset Reports Fiscal Year End 2009 Financial Results 9Pharmasset Reports Fiscal Year End 2009 Financial Results 10Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 5ULURU Inc Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30 2009 and to Provide a Business Update 5953 1ULURU Inc Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30 2009 and to Provide a Business Update 5953 2Depression May Blur Memory of Aches and Pains 60609 1Depression May Blur Memory of Aches and Pains 60609 2Study of concurrent radiotherapy chemotherapy shows promise in small cell lung cancer 60605 1Study of concurrent radiotherapy chemotherapy shows promise in small cell lung cancer 60605 2Study of concurrent radiotherapy chemotherapy shows promise in small cell lung cancer 60605 3
    ...- Bayer HealthCare,Pharmaceuticals announced today...ron(R) (interferon beta-1b), presented this week,a...nnual Meeting,demonstrating early efficacy, long-...ith treatment in patients with relapsing,forms of ...udies highlight the important clinical,benefits an...
    ...hange, EDMONTON, May 02, 2007 /PRNewswire-FirstCal...y") Quest is pleased to provide an,update on the p...,of prostate cancer. , Prostate cancer is the seco...ith approximately 230,000 new cases and 30,000 dea...ocalized prostate,cancer are associated with signi...
    Other Medicine Technology:Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4Quest PharmaTech's Prostate Cancer Program Update 2Quest PharmaTech's Prostate Cancer Program Update 3
    syngoDynamics
    ... Magnetic Navigation System™, the worlds fir...h digital flat panel detectors in both planes, whi...ccuracy of catheter-based procedures to facilitate...tional medicine. The new technology features a bip...
    ...d of imaging applications possibilities, from univ...rocedures. A veritable workhorse for all occasions...oductivity of your department., System highlight...d "room-mobile design , Broad applications spect...
    AXIOM Artis BC
    Medicine Products: